| |
|
|
| Name: |
Vestal Point Capital LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10012 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
16 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
CYTK |
Cytokinetics Inc |
1 |
- |
$48.30 |
$150,737,000 |
2,150,000 |
12.47% |
146,562,000 |
2,100,000 |
1.754 |
Biotechnology |
|
|
JAZZ |
Jazz Pharmaceuticals Inc |
2 |
- |
$109.27 |
$132,462,000 |
1,100,000 |
10.95% |
43,287,000 |
375,000 |
1.799 |
Biotechnology |
|
|
GMED |
Genomed Inc |
5 |
- |
$65.82 |
$53,640,000 |
1,000,000 |
4.44% |
11,008,000 |
200,000 |
0.867 |
N/A |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
7 |
- |
$147.76 |
$52,308,000 |
350,000 |
4.33% |
45,609,000 |
315,000 |
0.284 |
Biotechnology |
|
|
APLT |
Applied Therapeutics Inc. |
10 |
- |
$0.00 |
$34,748,000 |
5,110,000 |
2.87% |
20,829,000 |
955,000 |
6.617 |
N/A |
|
|
LQDA |
Liquidia Technologies Inc |
11 |
- |
$12.42 |
$29,500,000 |
2,000,000 |
2.44% |
17,169,000 |
975,000 |
5.298 |
N/A |
|
|
ALXO |
Alx Oncology Holdings Inc |
12 |
- |
$0.00 |
$29,102,000 |
2,610,000 |
2.41% |
4,459,000 |
955,000 |
5.239 |
N/A |
|
|
AZN |
AstraZeneca Plc (ADR) |
13 |
- |
$78.54 |
$27,100,000 |
400,000 |
2.24% |
10,262,000 |
150,000 |
0.015 |
Drug Manufacturers - ... |
|
|
QURE |
uniQure B.V. |
14 |
- |
$4.76 |
$24,570,000 |
4,725,000 |
2.03% |
-2,002,000 |
800,000 |
10.618 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
17 |
- |
$0.00 |
$17,220,000 |
400,000 |
1.42% |
9,159,000 |
225,000 |
0.531 |
N/A |
|
|
SLDB |
Solid Biosciences Inc |
22 |
- |
$7.79 |
$13,786,000 |
1,035,000 |
1.14% |
13,577,000 |
1,000,915 |
5.291 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
23 |
- |
$0.70 |
$13,650,000 |
455,000 |
1.13% |
12,246,000 |
320,000 |
3.07 |
N/A |
|
|
ACLX |
Arcellx, Inc. |
35 |
- |
$0.00 |
$6,955,000 |
100,000 |
0.58% |
3,625,000 |
40,000 |
0.204 |
N/A |
|
|
RLMD |
Relmada Therapeutics, Inc. |
43 |
- |
$3.05 |
$5,580,000 |
1,200,000 |
0.46% |
5,104,000 |
1,085,000 |
4.327 |
N/A |
|
|
PRME |
Prime Medicine, Inc. |
50 |
- |
$6.93 |
$2,520,000 |
360,000 |
0.21% |
2,340,000 |
339,694 |
0.37 |
N/A |
|
|
ACHL |
Achilles Therapeutics Ameri... |
54 |
- |
$0.00 |
$1,875,000 |
1,500,000 |
0.16% |
1,779,000 |
1,391,917 |
3.693 |
N/A |
|
